30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Gilead Pharmasset LLC (VRUS)

Track

Stock chart
Ticker: VRUS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Berrey M Michelle
Chief Medical Officer
2 sales — total 814,823 USD
Sale 1 Dec 2011
Value US$2,106,908.22 | Price 121.95 | Shares 24,242
Sale 1 Dec 2011
Value US$1,306,121.45 | Price 233.37 | Shares 10,417
Sale 1 Nov 2011
Value US$2,210,062.62 | Price 488.69 | Shares 79,177
Sale 1 Nov 2011
Value US$232,925.44 | Price 74.56 | Shares 3,124
Sale 3 Oct 2011
Value US$3,173,316.00 | Price 79.33 | Shares 40,000
Sale 1 Sep 2011
Value US$2,625,032.00 | Price 65.63 | Shares 40,000
Sale 1 Sep 2011
Value US$205,015.00 | Price 65.63 | Shares 3,124
Sale 1 Aug 2011
Value US$2,403,006.00 | Price 120.15 | Shares 20,000
Sale 1 Aug 2011
Value US$1,071,390.71 | Price 119.99 | Shares 8,929
Sale 1 Aug 2011
Value US$112,430.63 | Price 119.99 | Shares 937
Sale 1 Jul 2011
Value US$2,209,326.00 | Price 110.47 | Shares 20,000
Sale 1 Jul 2011
Value US$104,896.54 | Price 111.83 | Shares 938
Sale 1 Jun 2011
Value US$2,010,706.00 | Price 100.54 | Shares 20,000
Sale 9 May 2011
Value US$1,090,800.00 | Price 109.08 | Shares 10,000
Sale 6 May 2011
Value US$3,304,606.76 | Price 104.36 | Shares 31,666
Sale 6 May 2011
Value US$1,161,206.56 | Price 102.88 | Shares 11,287
Sale 5 May 2011
Value US$979,515.06 | Price 102.61 | Shares 9,546
Sale 3 May 2011
Value US$3,961,584.00 | Price 99.04 | Shares 40,000
Sale 28 Apr 2011
Value US$948,575.00 | Price 99.85 | Shares 9,500
Sale 27 Apr 2011
Value US$1,980,068.00 | Price 99.00 | Shares 20,000
Sale 27 Apr 2011
Value US$943,125.00 | Price 100.60 | Shares 9,375
Sale 27 Apr 2011
Value US$848,762.20 | Price 100.60 | Shares 8,437
Sale 27 Apr 2011
Value US$2,200,625.00 | Price 100.60 | Shares 21,875
Sale 27 Apr 2011
Value US$1,047,849.60 | Price 100.60 | Shares 10,416
Sale 22 Mar 2011
Value US$401,856.00 | Price 64.00 | Shares 6,279
Sale 1 Oct 2010
Value US$147,500.00 | Price 29.50 | Shares 5,000
Sale 28 Sep 2010
Value US$377,924.50 | Price 29.50 | Shares 12,811
Sale 17 Jun 2010
Value US$96,806.90 | Price 32.53 | Shares 2,976
Sale 24 Sep 2009
Value US$8,352,000.00 | Price 20.88 | Shares 400,000
Sale 24 Sep 2009
Value US$8,352,000.00 | Price 20.88 | Shares 400,000
Sale 23 Sep 2009
Value US$224,100.00 | Price 22.41 | Shares 10,000
Sale 22 Sep 2009
Value US$2,295,000.00 | Price 22.95 | Shares 100,000
Sale 18 Sep 2009
Value US$101,062.00 | Price 21.97 | Shares 4,600
Sale 18 Sep 2009
Value US$98,775.00 | Price 21.95 | Shares 4,500
Sale 18 Sep 2009
Value US$179,908.00 | Price 21.94 | Shares 8,200
Sale 18 Sep 2009
Value US$203,856.00 | Price 21.92 | Shares 9,300
Sale 18 Sep 2009
Value US$293,460.00 | Price 21.90 | Shares 13,400
Buy 27 Feb 2009
Value US$2,021.98 | Price 10.11 | Shares 200
Buy 27 Feb 2009
Value US$1,939.18 | Price 10.10 | Shares 192
Buy 27 Feb 2009
Value US$3,026.97 | Price 10.09 | Shares 300
Buy 27 Feb 2009
Value US$584.06 | Price 10.07 | Shares 58
Buy 27 Feb 2009
Value US$5,052.75 | Price 10.11 | Shares 500
Buy 26 Feb 2009
Value US$1,270.91 | Price 10.68 | Shares 119
Buy 26 Feb 2009
Value US$1,066.99 | Price 10.67 | Shares 100
Buy 26 Feb 2009
Value US$2,127.98 | Price 10.64 | Shares 200
Buy 26 Feb 2009
Value US$3,194.97 | Price 10.65 | Shares 300
Buy 26 Feb 2009
Value US$3,188.97 | Price 10.63 | Shares 300
Buy 26 Feb 2009
Value US$1,388.59 | Price 10.60 | Shares 131
Buy 26 Feb 2009
Value US$1,058.50 | Price 10.59 | Shares 100
Buy 25 Feb 2009
Value US$1,267.50 | Price 10.14 | Shares 125
Buy 25 Feb 2009
Value US$1,863.75 | Price 10.65 | Shares 175
Buy 25 Feb 2009
Value US$2,128.00 | Price 10.64 | Shares 200
Sale 13 Nov 2008
Value US$11,250.00 | Price 18.75 | Shares 600
Sale 13 Nov 2008
Value US$18.72 | Price 18.72 | Shares 1
Sale 13 Nov 2008
Value US$5,613.00 | Price 18.71 | Shares 300
Sale 13 Nov 2008
Value US$5,610.00 | Price 18.70 | Shares 300
Sale 13 Nov 2008
Value US$9,326.31 | Price 18.69 | Shares 499
Sale 13 Nov 2008
Value US$13,073.65 | Price 18.65 | Shares 701
Sale 13 Nov 2008
Value US$1,863.00 | Price 18.63 | Shares 100
Sale 13 Nov 2008
Value US$1,859.00 | Price 18.59 | Shares 100
Sale 13 Nov 2008
Value US$3,716.00 | Price 18.58 | Shares 200
Sale 13 Nov 2008
Value US$1,836.45 | Price 18.55 | Shares 99
Sale 13 Nov 2008
Value US$11,100.00 | Price 18.50 | Shares 600
Sale 13 Nov 2008
Value US$5,529.00 | Price 18.43 | Shares 300
Sale 13 Nov 2008
Value US$5,520.00 | Price 18.40 | Shares 300
Sale 13 Nov 2008
Value US$1,287.30 | Price 18.39 | Shares 70
Sale 13 Nov 2008
Value US$1,838.00 | Price 18.38 | Shares 100
Sale 13 Nov 2008
Value US$1,837.00 | Price 18.37 | Shares 100
Sale 13 Nov 2008
Value US$26,240.50 | Price 18.35 | Shares 1,430
Sale 13 Nov 2008
Value US$7,328.00 | Price 18.32 | Shares 400
Sale 13 Nov 2008
Value US$5,487.00 | Price 18.29 | Shares 300
Sale 13 Nov 2008
Value US$7,308.00 | Price 18.27 | Shares 400
Sale 13 Nov 2008
Value US$7,304.00 | Price 18.26 | Shares 400
Sale 13 Nov 2008
Value US$30,514.00 | Price 18.25 | Shares 1,672
Sale 13 Nov 2008
Value US$10,944.00 | Price 18.24 | Shares 600
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2011-12-05 2011-12-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
24,242 -1.4%
121.95
US$2,106,908 		24,242 -1.4% 121.95 US$2,106,908
2011-12-05 2011-12-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
10,417 +23.1%
233.37
US$1,306,121 		10,417 +23.1% 233.37 US$1,306,121
2011-11-07 2011-11-01 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
79,177 +17.4%
488.69
US$2,210,063 		79,177 +17.4% 488.69 US$2,210,063
2011-11-03 2011-11-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
3,124 -100.0%
74.56
US$232,925 		3,124 -100.0% 74.56 US$232,925
2011-10-05 2011-10-03 S Sale Price P Schaefer

President & CEO

Executive Director
40,000 -5.0%
79.33
US$3,173,316 		40,000 -5.0% 79.33 US$3,173,316
2011-09-06 2011-09-01 S Sale Price P Schaefer

President and CEO

Executive Director
40,000 -5.0%
65.63
US$2,625,032 		40,000 -5.0% 65.63 US$2,625,032
2011-09-06 2011-09-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
3,124 -100.0%
65.63
US$205,015 		3,124 -100.0% 65.63 US$205,015
2011-08-03 2011-08-01 S Sale Price P Schaefer

President and CEO

Executive Director
20,000 -5.0%
120.15
US$2,403,006 		20,000 -5.0% 120.15 US$2,403,006
2011-08-03 2011-08-01 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
8,929 -55.4%
119.99
US$1,071,391 		8,929 -55.4% 119.99 US$1,071,391
2011-08-03 2011-08-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
937 -100.0%
119.99
US$112,431 		937 -100.0% 119.99 US$112,431
2011-07-05 2011-07-01 S Sale Price P Schaefer

President and CEO

Executive Director
20,000 -5.0%
110.47
US$2,209,326 		20,000 -5.0% 110.47 US$2,209,326
2011-07-05 2011-07-01 S Sale Berrey M Michelle

Chief Medical Officer

Officer
938 -100.0%
111.83
US$104,897 		938 -100.0% 111.83 US$104,897
2011-06-03 2011-06-01 S Sale Price P Schaefer

President and CEO

Executive Director
20,000 -5.0%
100.54
US$2,010,706 		20,000 -5.0% 100.54 US$2,010,706
2011-05-11 2011-05-09 S Sale Rogers Michael D.

Chief Development Officer

Officer
10,000 -100.0%
109.08
US$1,090,800 		10,000 -100.0% 109.08 US$1,090,800
2011-05-10 2011-05-06 S Sale Williamson Robert F III Non-Executive Director
31,666 -91.3%
104.36
US$3,304,607 		31,666 -91.3% 104.36 US$3,304,607
2011-05-10 2011-05-06 S Sale LEUTZINGER KURT

Chief Financial Officer

Officer
11,287 -5.7%
102.88
US$1,161,207 		11,287 -5.7% 102.88 US$1,161,207
2011-05-09 2011-05-05 S Sale LEUTZINGER KURT

Chief Financial Officer

Officer
9,546 -4.6%
102.61
US$979,515 		9,546 -4.6% 102.61 US$979,515
2011-05-05 2011-05-03 S Sale CONRAD HERBERT J Non-Executive Director
40,000 -83.3%
99.04
US$3,961,584 		40,000 -83.3% 99.04 US$3,961,584
2011-04-29 2011-04-28 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
9,500 -56.9%
99.85
US$948,575 		9,500 -56.9% 99.85 US$948,575
2011-04-29 2011-04-27 S Sale Rogers Michael D.

Chief Development Officer

Officer
20,000 -100.0%
99.00
US$1,980,068 		20,000 -100.0% 99.00 US$1,980,068
2011-04-29 2011-04-27 S Sale Berrey M Michelle

Chief Medical Officer

Officer
9,375 -100.0%
100.60
US$943,125 		9,375 -100.0% 100.60 US$943,125
2011-04-29 2011-04-27 S Sale Berrey M Michelle

Chief Medical Officer

Officer
8,437 -100.0%
100.60
US$848,762 		8,437 -100.0% 100.60 US$848,762
2011-04-29 2011-04-27 S Sale Berrey M Michelle

Chief Medical Officer

Officer
21,875 -100.0%
100.60
US$2,200,625 		21,875 -100.0% 100.60 US$2,200,625
2011-04-29 2011-04-27 S Sale Berrey M Michelle

Chief Medical Officer

Officer
10,416 -100.0%
100.60
US$1,047,850 		10,416 -100.0% 100.60 US$1,047,850
2011-03-24 2011-03-22 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
6,279 -27.3%
64.00
US$401,856 		6,279 -27.3% 64.00 US$401,856
2010-10-01 2010-10-01 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
5,000 -23.1%
29.50
US$147,500 		5,000 -23.1% 29.50 US$147,500
2010-09-29 2010-09-28 S Sale OTTO MICHAEL J.

Chief Scientific Officer

Officer
12,811 -37.1%
29.50
US$377,924 		12,811 -37.1% 29.50 US$377,924
2010-06-18 2010-06-17 S Sale Berrey M Michelle

Chief Medical Officer

Officer
2,976 -100.0%
32.53
US$96,807 		2,976 -100.0% 32.53 US$96,807
2009-09-24 2009-09-24 S Sale QVT Associates GP LLC Large shareholder
400,000 -12.5%
20.88
US$8,352,000 		400,000 -12.5% 20.88 US$8,352,000
2009-09-24 2009-09-24 S Sale QVT Associates GP LLC Large shareholder
400,000 -11.1%
20.88
US$8,352,000 		400,000 -11.1% 20.88 US$8,352,000
2009-09-24 2009-09-23 S Sale QVT Associates GP LLC Large shareholder
10,000 -0.3%
22.41
US$224,100 		10,000 -0.3% 22.41 US$224,100
2009-09-24 2009-09-22 S Sale QVT Associates GP LLC Large shareholder
100,000 -2.7%
22.95
US$2,295,000 		100,000 -2.7% 22.95 US$2,295,000
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
4,600 -19.1%
21.97
US$101,062 		4,600 -19.1% 21.97 US$101,062
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
4,500 -65.1%
21.95
US$98,775 		4,500 -65.1% 21.95 US$98,775
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
8,200 -22.3%
21.94
US$179,908 		8,200 -22.3% 21.94 US$179,908
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
9,300 -20.2%
21.92
US$203,856 		9,300 -20.2% 21.92 US$203,856
2009-09-21 2009-09-18 S Sale OTTO MICHAEL

Exec.VP,Pharm.Research

Officer
13,400 -22.5%
21.90
US$293,460 		13,400 -22.5% 21.90 US$293,460
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
200 +4.7%
10.11
US$2,022 		200 +4.7% 10.11 US$2,022
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
192 +4.7%
10.10
US$1,939 		192 +4.7% 10.10 US$1,939
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
300 +7.9%
10.09
US$3,027 		300 +7.9% 10.09 US$3,027
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
58 +1.5%
10.07
US$584 		58 +1.5% 10.07 US$584
2009-03-02 2009-02-27 B Purchase INOUYE MICHAEL K Non-Executive Director
500 +15.4%
10.11
US$5,053 		500 +15.4% 10.11 US$5,053
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
119 +3.8%
10.68
US$1,271 		119 +3.8% 10.68 US$1,271
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
100 +3.3%
10.67
US$1,067 		100 +3.3% 10.67 US$1,067
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
200 +7.1%
10.64
US$2,128 		200 +7.1% 10.64 US$2,128
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
300 +11.9%
10.65
US$3,195 		300 +11.9% 10.65 US$3,195
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
300 +13.4%
10.63
US$3,189 		300 +13.4% 10.63 US$3,189
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
131 +6.2%
10.60
US$1,389 		131 +6.2% 10.60 US$1,389
2009-03-02 2009-02-26 B Purchase INOUYE MICHAEL K Non-Executive Director
100 +5.0%
10.59
US$1,058 		100 +5.0% 10.59 US$1,058
2009-02-26 2009-02-25 B Purchase LUBETKIN PAUL

Executive VP & General Counsel

Officer
125 +33.3%
10.14
US$1,268 		125 +33.3% 10.14 US$1,268
2009-02-26 2009-02-25 B Purchase LUBETKIN PAUL

Executive VP & General Counsel

Officer
175 +87.5%
10.65
US$1,864 		175 +87.5% 10.65 US$1,864
2009-02-26 2009-02-25 B Purchase LUBETKIN PAUL

Executive VP & General Counsel

Officer
200 +inf%
10.64
US$2,128 		200 +inf% 10.64 US$2,128
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
600 -100.0%
18.75
US$11,250 		600 -100.0% 18.75 US$11,250
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
1 -0.2%
18.72
US$19 		1 -0.2% 18.72 US$19
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -33.3%
18.71
US$5,613 		300 -33.3% 18.71 US$5,613
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -25.0%
18.70
US$5,610 		300 -25.0% 18.70 US$5,610
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
499 -29.4%
18.69
US$9,326 		499 -29.4% 18.69 US$9,326
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
701 -29.2%
18.65
US$13,074 		701 -29.2% 18.65 US$13,074
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
100 -4.0%
18.63
US$1,863 		100 -4.0% 18.63 US$1,863
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
100 -3.3%
18.59
US$1,859 		100 -3.3% 18.59 US$1,859
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
200 -6.2%
18.58
US$3,716 		200 -6.2% 18.58 US$3,716
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
99 -3.0%
18.55
US$1,836 		99 -3.0% 18.55 US$1,836
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
600 -15.4%
18.50
US$11,100 		600 -15.4% 18.50 US$11,100
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -7.1%
18.43
US$5,529 		300 -7.1% 18.43 US$5,529
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -6.7%
18.40
US$5,520 		300 -6.7% 18.40 US$5,520
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
70 -1.5%
18.39
US$1,287 		70 -1.5% 18.39 US$1,287
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
100 -2.1%
18.38
US$1,838 		100 -2.1% 18.38 US$1,838
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
100 -2.1%
18.37
US$1,837 		100 -2.1% 18.37 US$1,837
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
1,430 -23.1%
18.35
US$26,240 		1,430 -23.1% 18.35 US$26,240
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
400 -6.1%
18.32
US$7,328 		400 -6.1% 18.32 US$7,328
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
300 -4.3%
18.29
US$5,487 		300 -4.3% 18.29 US$5,487
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
400 -5.5%
18.27
US$7,308 		400 -5.5% 18.27 US$7,308
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
400 -5.2%
18.26
US$7,304 		400 -5.2% 18.26 US$7,304
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
1,672 -17.8%
18.25
US$30,514 		1,672 -17.8% 18.25 US$30,514
2008-11-17 2008-11-13 S Sale Rogers Michael D.

Chief Development Officer

Officer
600 -6.0%
18.24
US$10,944 		600 -6.0% 18.24 US$10,944
Explore more

More insider trading research around Gilead Pharmasset LLC

More insider trades in United States
Insider trading in North America